Xience Stents Gain European Nod For Three-Month Dual Antiplatelet Therapy Forbes Now the Xience Prime and Xience V everolimus-eluting stents have received the CE Mark in Europe for a DAPT length of only three months, according to an Abbott press release. The manufacturer of the stents, Abbott, said this was the “shortest duration ... |
